Home | Structured Search | Drug Resource
Find: within
Malaria > Diagnosis Author: Rick M. Fairhurst, MD, PhD; Thomas E. Wellems, MD, PhD
Module updated - 2009-11-19
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Probabilities of specific disease are affected by geographic area visited, type of travel, time of travel, type of food and water ingested, and vaccination history.
  • Yellow fever is not prevalent in Asia or India.
  • Adventure travelers to the Rift Valley are more likely to acquire schistosomiasis or leptospirosis from fresh water contact than are visitors to Nairobi, Kenya.
  • Dengue is less likely to be acquired during the dry season, when mosquito transmission is markedly reduced.
  • Enteric fever relatively unlikely in persons eating only cooked food and bottled water.
  • The efficacy of yellow fever, hepatitis A and B vaccines makes these diseases unlikely if patient is vaccinated.

Evidence:

  • Consensus.

Comments:

  • Rapid diagnostic tests for several diseases are often limited or not available.
  • Malaria should always lead the list in the differential diagnoses of fever in travelers or immigrants who have been in an endemic area within the previous 3 months. Although these persons often present with common ailments, physicians must be alert to recognize and treat malaria to avoid a tragic outcome.
  • Like malaria, several diseases are unlikely to be considered by physicians not well-acquainted with tropical diseases; are seen with appreciable frequency among U.S. travelers returning from malarious areas; can present clinically within 2 months of exposure; and may be serious or life-threatening if not treated with specific antibiotic drugs.
  • Definitive diagnoses often rely on nonroutine methods of pathogen isolation or serologic testing that relies on serologic comparisons of acute and convalescent (2 to 4 weeks later) antibody titers. For example, the diagnosis of dengue virus infection in the U.S. requires that acute and convalescent serum samples be sent through state health departments to the CDC's Dengue Branch.

FAQs
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.